In September 2019, it successfully signed a contract with the Guangdong-Hong Kong-Macao Phase I clinical research joint platform to jointly build a subject database
In September 2019, it successfully signed a contract with the Guangdong-Hong Kong-Macao Phase I clinical research joint platform to jointly build a subject database